Webcast Provides Perspective on Generic Imatinib

On February 1, 2016, the commercial launch of the generic version of imatinib mesylate (Gleevec), originally for CML (Chronic Myeloid Leukemia), was approved by the FDA and became available for the first time in the United States through Sun Pharmaceuticals. In response to this transition, the LRG provided an educational Webinar to the CML and GIST communities on March 18th entitled “Generic Imatinib: Gaining Perspective.”

By |2020-07-09T15:58:49-04:00April 8th, 2016|Generics, GIST Education, Webcast|

The Heart of the Matter: Cardiac Health for GIST Patients

The heart is at the center of the cardiovascular system, the main function of which is to pump blood throughout the body, providing tissue and organs with the oxygen and nutrients they need. To [...]

By |2019-09-20T15:37:59-04:00February 10th, 2016|GIST Education, Newsletter, Side Effects|

Henzo Kenya Holds Psychological Support and Wellness Conference

Henzo Kenya,  the CML and GIST support organization in Kenya, Africa held a conference at the Nairobi Hospital in the New Lecture Theatre Hall on Psychological Support and Wellness [...]

By |2020-09-18T11:02:16-04:00November 3rd, 2015|Events, GIST Education, News, Patient Support|

Rol de los Hallazgos Histopatologicos y del Analisis Molecular en el Tratamiento del GIST

Rol de los Hallazgos Histopatologicos y del Analisis Molecular en el Tratamiento del GIST presentación del Monica Garcia-Buitrago, October 30, 2015.

By |2020-07-09T15:03:08-04:00October 30th, 2015|GIST Education, Global, Video|

Informative Webcast Sheds Light on Mutational Analysis

Dr. Chris Corless In August, the LRG Webcast Series presented “Mutational Analysis of GISTs: How, When and Why.” Dr. Christopher Corless of Oregon Health and Science University (OHSU) presented the hour- long [...]

Go to Top